Bookmark and Share

Celgene Corporation Director Buys 1,000 Shares (CELG)

Celgene Corporation (NASDAQ: CELG) director Ernest Mario bought 1,000 shares of CELG common stock for $123.72 per share, according to a SEC filing. Mario made a total investment of $123,725.

[...]

Bookmark and Share

Celgene Shares Gain after FDA Approval for POMALYST® (CELG)

Shares of Celgene Corporation (NASDAQ: CELG), a global biopharmaceutical company engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases, have edged higher in pre-market trading today after the company’s POMALYST® was approved by the U.S. Food and Drug Administration (FDA).

[...]


-------------------------------------------------------------------------------------------------------------------------
All stories in DailyStocks.com are for informational purposes only. This is NOT a stock recommendation. This DailyStocks.com story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at DailyStocks.com . About Dailystocks.com: DailyStocks.com is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.